Chronic News and Research

RSS

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.

5 Mar 2024

Researchers examine the immune response of a hypervaccinated individual

Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen have examined a man who has received more than 200 vaccinations against Covid-19. They learned of his case via newspaper reports.

5 Mar 2024

Lack of sleep linked to higher risk of developing type 2 diabetes

Adults who sleep only three to five hours a day are at higher risk of developing type 2 diabetes. This is demonstrated in a new study from Uppsala University, published in JAMA Network Open.

5 Mar 2024

Nomogram could be a game-changer for predicting alcohol-related liver cancer risk

Liver cancer, unfortunately, is the sixth most common cancer and the third most frequent cause of cancer-related death globally.

5 Mar 2024

International commission examines conflicting evidence on health effects of blue light exposure

For years, scientists have expressed concern about potential adverse health effects of excessive exposure to short wavelength light (SWL), which includes the "blue light" from smartphones, laptops, and tablets.

5 Mar 2024

FDA Clears Beckman Coulter Life Sciences DxFLEX Flow Cytometer

...

From Beckman Coulter Life Sciences - Flow Cytometry 5 Mar 2024

New hope for binge eating and bulimia: GLP-1 drugs could be the key

GLP-1 receptor agonists show promise in reducing binge eating behaviors in disorders like bulimia nervosa, offering a new avenue for treatment with minimal side effects.

4 Mar 2024

Inexpensive liquid works as well as dental sealants to keep tooth decay at bay

An inexpensive, cavity-fighting liquid called silver diamine fluoride (SDF) works as well as dental sealants to keep tooth decay at bay in a school cavity prevention and treatment program, according to a new study by researchers at NYU College of Dentistry.

4 Mar 2024

Robotic hip exoskeleton could be a promising avenue for stroke rehabilitation

More than 80% of stroke survivors experience walking difficulty, significantly impacting their daily lives, independence, and overall quality of life.

4 Mar 2024

Disrupting the Flow: Dr. Naseri's Revolutionary Approach to Empowering Women's Health

An interview with Dr. Sara Naseri, the CEO and Co-Founder of the women’s health company, Qvin.

4 Mar 2024

Iron dysregulation identified as potential trigger for long COVID

Problems with iron levels in the blood and the body's ability to regulate this important nutrient as a result of SARS-CoV-2 infection could be a key trigger for long COVID, new research has discovered.

4 Mar 2024

Is air pollution associated with increased incidence of myocardial infarction and cardiogenic shock?

The association between prolonged exposure to air pollution (AP) and ST-elevation myocardial infarction.

4 Mar 2024

Researchers discover how "leaky" mitochondria can drive harmful inflammation

Researchers have discovered how "leaky" mitochondria – the powerhouses of our cells – can drive harmful inflammation responsible for diseases such as lupus and rheumatoid arthritis.

4 Mar 2024

SolasCure publishes phase IIa clinical trial report in leading wound care journal

Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounds.

From SolasCure 4 Mar 2024

Clinigen launches 'What is Possible?' campaign to expand access to rare disease treatments

Clinigen, the global pharmaceutical services company, today launched a new campaign called ‘What is Possible?’ to help empower patients and medical professionals to ask what more is possible in the treatment of rare diseases.

4 Mar 2024

PharmaKure partners with Sheffield Hallam University to develop epigenetic markers for Alzheimer’s disease prediction

PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease (AD) and other neurodegenerative diseases, today announces a new epigenetics collaboration with Sheffield Hallam University.

4 Mar 2024

The impact of quinoa bioactive compounds on gut health

Researchers review the beneficial impacts of quinoa and its bioactive compounds, particularly its effects on intestinal microflora.

4 Mar 2024

Only 9% of older Americans vaccinated against RSV, study finds

A new study from the Texas A&M University School of Public Health found that only 9 percent of older Americans had been vaccinated against respiratory syncytial virus (RSV) prior to this fall and winter, despite the threat of increased rates of hospitalization and deaths nationwide from the virus.

1 Mar 2024

Nerve overgrowth identified as cause of pain in recurring UTIs

A perplexing problem for people with recurring urinary tract infections (UTIs) is persistent pain, even after antibiotics have successfully cleared the bacteria.

1 Mar 2024

Educational attainment linked to slower aging and increased longevity

Participants in the Framingham Heart Study who achieved higher levels of education tended to age more slowly and went on to live longer lives as compared to those who did not achieve upward educational mobility, according to a new study at Columbia University Mailman School of Public Health and The Robert N. Butler Columbia Aging Center.

1 Mar 2024

Chronic News and Research

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

Researchers examine the immune response of a hypervaccinated individual

Lack of sleep linked to higher risk of developing type 2 diabetes

Nomogram could be a game-changer for predicting alcohol-related liver cancer risk

International commission examines conflicting evidence on health effects of blue light exposure

FDA Clears Beckman Coulter Life Sciences DxFLEX Flow Cytometer

New hope for binge eating and bulimia: GLP-1 drugs could be the key

Inexpensive liquid works as well as dental sealants to keep tooth decay at bay

Robotic hip exoskeleton could be a promising avenue for stroke rehabilitation

Disrupting the Flow: Dr. Naseri's Revolutionary Approach to Empowering Women's Health

Iron dysregulation identified as potential trigger for long COVID

Is air pollution associated with increased incidence of myocardial infarction and cardiogenic shock?

Researchers discover how "leaky" mitochondria can drive harmful inflammation

SolasCure publishes phase IIa clinical trial report in leading wound care journal

Clinigen launches 'What is Possible?' campaign to expand access to rare disease treatments

PharmaKure partners with Sheffield Hallam University to develop epigenetic markers for Alzheimer’s disease prediction

The impact of quinoa bioactive compounds on gut health

Only 9% of older Americans vaccinated against RSV, study finds

Nerve overgrowth identified as cause of pain in recurring UTIs

Educational attainment linked to slower aging and increased longevity

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News